Etodolac
- Product NDC
- 43063-834
- 11-digit product format
- 430630834
- Labeler code
- 43063
- Product ID
- 43063-834_d683ce9c-195f-233f-e053-2a95a90a85f3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Etodolac
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Application
- ANDA074903
- Marketing category
- ANDA
- Marketing start
- 2015-04-20
- Marketing end
- 0000-00-00
- Substance
- ETODOLAC
- Active strength
- 400 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43063-834 | ETODOLAC TABLET, COATED [PD-RX PHARMACEUTICALS, INC.] | 19 | Legacy NDC | 20241017_719ff8a0-fbf3-46f6-86eb-d6b7b0cc66dc.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43063-834-60 | 43063083460 | 60 TABLET, COATED in 1 BOTTLE, PLASTIC (43063-834-60) | 2018-02-06 | 0000-00-00 | No | No | Current |